Junjie Xu

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1

Junjie Xu, Lin Ji, Yuelong Liang et al. · Signal Transduction and Targeted Therapy · 2020 · 548 citations · Full text

Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up

Mengxia Zhang, Jing Li, Guo‐Ping Shen et al. · European Journal of Cancer · 2015 · 318 citations

Adaptive Radiotherapy, Radiation Therapy, Conventional Two-dimensional Radiotherapy +8

N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling

Junjie Xu, Zhe Wan, Minyue Tang et al. · Molecular Cancer · 2020 · 316 citations · Full text

Magnetic Nanomaterials: Chemical Design, Synthesis, and Potential Applications

Kai Zhu, Yanmin Ju, Junjie Xu et al. · Accounts of Chemical Research · 2018 · 315 citations

Evidence for Pore Formation in Host Cell Membranes by ESX-1-Secreted ESAT-6 and Its Role in <i>Mycobacterium marinum</i> Escape from the Vacuole

Jennifer Smith, Joanna Manoranjan, Miao Pan et al. · Infection and Immunity · 2008 · 290 citations · Full text